/term/marke-table-securities/FRA:BS50 Inotiv (FRA:BS50) Marketable Securities
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (FRA:BS50) » Definitions » Marketable Securities

Inotiv (FRA:BS50) Marketable Securities : €0.0 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Inotiv Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Inotiv's Marketable Securities for the quarter that ended in Mar. 2024 was €0.0 Mil.


Inotiv Marketable Securities Historical Data

The historical data trend for Inotiv's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inotiv Marketable Securities Chart

Inotiv Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Inotiv Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Inotiv Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Inotiv  (FRA:BS50) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Inotiv Marketable Securities Related Terms

Thank you for viewing the detailed overview of Inotiv's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Inotiv (FRA:BS50) Business Description

Traded in Other Exchanges
Address
2701 Kent Avenue, West Lafayette, IN, USA, 47906
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Inotiv (FRA:BS50) Headlines

No Headlines